Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis.
Animals
Case-Control Studies
Chemokine CCL20
/ genetics
Chemokines
/ genetics
Cluster Analysis
Hepatitis C, Chronic
/ immunology
Hepatitis, Alcoholic
/ genetics
Hepatocytes
/ immunology
Humans
Intramolecular Oxidoreductases
/ genetics
Lipopolysaccharides
Liver
/ immunology
Macrophage Migration-Inhibitory Factors
/ genetics
Mice
Mice, Knockout
Non-alcoholic Fatty Liver Disease
/ immunology
RNA-Seq
Chemokines
Hepatitis
Hepatology
Inflammation
Innate immunity
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
08 06 2021
08 06 2021
Historique:
received:
10
07
2020
accepted:
28
04
2021
pubmed:
5
5
2021
medline:
15
2
2022
entrez:
4
5
2021
Statut:
epublish
Résumé
The chemokine system of ligands and receptors is implicated in the progression of alcohol-associated hepatitis (AH). Finding upstream regulators could lead to novel therapies. This study involved coordinated expression of chemokines in livers of healthy controls (HC) and patients with AH in 2 distinct cohorts of patients with various chronic liver diseases. Studies in cultured hepatocytes and in tissue-specific KO were used for mechanistic insight into a potential upstream regulator of chemokine expression in AH. Selected C-X-C chemokine members of the IL-8 chemokine family and C-C chemokine CCL20 were highly associated with AH compared with HC but not in patients with liver diseases of other etiologies (nonalcoholic fatty liver disease [NAFLD] and hepatitis C virus [HCV]). Our previous studies implicate macrophage migration inhibitory factor (MIF) as a pleiotropic cytokine/chemokine with the potential to coordinately regulate chemokine expression in AH. LPS-stimulated expression of multiple chemokines in cultured hepatocytes was dependent on MIF. Gao-binge ethanol feeding to mice induced a similar coordinated chemokine expression in livers of WT mice; this was prevented in hepatocyte-specific Mif-KO (MifΔHep) mice. This study demonstrates that patients with AH exhibit a specific, coordinately expressed chemokine signature and that hepatocyte-derived MIF might drive this inflammatory response.
Identifiants
pubmed: 33945507
pii: 141420
doi: 10.1172/jci.insight.141420
pmc: PMC8262327
doi:
pii:
Substances chimiques
Chemokine CCL20
0
Chemokines
0
Lipopolysaccharides
0
Macrophage Migration-Inhibitory Factors
0
Intramolecular Oxidoreductases
EC 5.3.-
MIF protein, human
EC 5.3.2.1
Mif protein, mouse
EC 5.3.2.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAAA NIH HHS
ID : U01 AA026938
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA023722
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA026648
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR049610
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021890
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA026648
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA024333
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020821
Pays : United States
Références
Handb Exp Pharmacol. 2018;248:347-367
pubmed: 29374837
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S
pubmed: 10803780
Aliment Pharmacol Ther. 2014 Aug;40(3):261-79
pubmed: 24890045
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7917-E7926
pubmed: 27872288
Hepatology. 2017 Aug;66(2):555-563
pubmed: 28120471
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9354-9
pubmed: 12878730
Hepatol Commun. 2020 Aug 04;4(10):1459-1476
pubmed: 33024916
PLoS One. 2011;6(6):e21381
pubmed: 21731723
Gut. 2013 Mar;62(3):452-60
pubmed: 22637703
Immunogenetics. 2002 Nov;54(8):599-603
pubmed: 12439624
Front Immunol. 2020 Apr 17;11:322
pubmed: 32362892
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
J Hepatol. 1996 Apr;24(4):377-84
pubmed: 8738722
J Immunol. 2006 Dec 1;177(11):8072-9
pubmed: 17114481
Gut. 2014 Nov;63(11):1782-92
pubmed: 24415562
J Hepatol. 2019 Feb;70(2):249-259
pubmed: 30658726
J Leukoc Biol. 1998 Oct;64(4):494-502
pubmed: 9766630
Alcohol Clin Exp Res. 2019 Jul;43(7):1439-1451
pubmed: 31009094
Thromb Haemost. 2013 Mar;109(3):391-8
pubmed: 23329140
Gastroenterology. 2014 Sep;147(3):577-594.e1
pubmed: 25066692
Gastroenterology. 2014 May;146(5):1231-9.e1-6
pubmed: 24440674
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17444-9
pubmed: 21969590
Hepatology. 2013 May;57(5):1980-91
pubmed: 23174952
Hepatology. 2015 Oct;62(4):1070-85
pubmed: 26033752
Nat Commun. 2019 Jul 16;10(1):3126
pubmed: 31311938
Sci Rep. 2016 Jun 08;6:27665
pubmed: 27273604
Front Genet. 2019 Jan 22;9:636
pubmed: 30723492
Hepatology. 2014 Feb;59(2):580-91
pubmed: 23913513
Free Radic Biol Med. 2013 Oct;63:236-42
pubmed: 23707455
BMC Genomics. 2005 Mar 24;6:45
pubmed: 15790398
Toxicol Mech Methods. 2007;17(7):431-40
pubmed: 20020946
Cell Mol Immunol. 2016 May;13(3):301-15
pubmed: 26685902
Hepatology. 2011 Dec;54(6):2185-97
pubmed: 21826694
Nat Protoc. 2013 Mar;8(3):627-37
pubmed: 23449255
Gastroenterology. 2009 May;136(5):1639-50
pubmed: 19208360
J Immunol. 2009 Jun 1;182(11):6896-906
pubmed: 19454686
FASEB J. 2014 Dec;28(12):5136-47
pubmed: 25122558
Cells. 2021 Jan 28;10(2):
pubmed: 33525493
Alcohol. 2002 May;27(1):23-7
pubmed: 12062633
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
J Hepatol. 2017 Nov;67(5):1018-1025
pubmed: 28647568
Cell Mol Immunol. 2014 Jan;11(1):25-40
pubmed: 23954947
Front Physiol. 2012 Jun 20;3:213
pubmed: 22723782
Gastroenterology. 1996 Jun;110(6):1847-53
pubmed: 8964410
Hepatology. 2013 Nov;58(5):1814-23
pubmed: 23532958